Catheter Precision Income Statement (2017-2026) | VTAK

Income Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
1.00M0.01M0.01M0.01M0.01M0.09M0.10M0.13M0.13M0.08M0.09M0.10M0.15M0.14M0.21M0.23M0.24M0.43M
Cost of Revenue (Quarter)
1.49M0.25M0.35M0.10M0.07M-0.04M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.02M0.02M0.04M
Gross Profit (Quarter)
-0.48M-0.24M-0.34M-0.09M-0.06M0.07M0.09M0.13M0.12M0.08M0.08M0.09M0.14M0.13M0.20M0.21M0.22M0.39M
Operating items
Research & Development (Quarter)
3.02M2.94M3.73M3.12M2.40M0.73M0.15M0.24M0.13M0.11M-0.01M0.04M0.08M0.06M0.09M0.10M0.15M0.28M0.33M0.15M
Selling, General & Administrative (Quarter)
3.74M4.21M4.19M2.30M2.48M3.51M7.96M10.23M1.42M2.75M2.73M2.66M2.71M2.88M3.10M3.48M2.88M2.95M2.76M2.56M
Other Operating Expenses (Quarter)
3.53M0.54M0.10M0.08M4.73M0.80M-76.36M-0.06M-1.50M-1.26M0.12M1.85M7.00M-0.10M
Operating Expenses (Quarter)
6.76M7.15M7.92M5.42M8.40M4.78M8.21M66.56M6.40M2.86M2.72M2.69M2.79M2.94M3.19M3.71M4.88M3.23M10.08M2.71M
Operating Income (Quarter)
-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M-2.32M
EBIT (Quarter)
-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M-2.32M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.02M-0.04M0.07M0.12M0.09M0.05M0.03M0.01M0.01M0.03M0.02M0.00M0.01M0.00M0.00M
Other Non Operating Income (Quarter)
2.02M0.02M-0.01M-0.01M0.01M0.02M0.06M0.01M-0.00M-0.02M-0.00M-0.00M-0.00M0.01M-0.00M-0.01M0.00M-0.01M
Non Operating Income (Quarter)
1.99M0.02M-0.02M-0.01M0.01M0.02M0.06M0.01M-0.00M7.54M-0.00M-1.50M-1.26M-2.25M-0.00M-0.01M2.16M0.45M
Net income details
EBT (Quarter)
-5.25M-7.38M-8.28M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-6.06M-1.86M
Tax Provisions (Quarter)
0.00M1.60M-0.17M
Profit After Tax (Quarter)
-5.25M-7.38M-6.10M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-5.63M-4.04M-5.46M-2.25M-5.34M-1.69M
Income from Non-Controlling Interests (Quarter)
-0.35M-0.09M-0.07M-0.01M
Income from Continuing Operations (Quarter)
-5.25M-7.38M-8.28M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M-1.69M
Consolidated Net Income (Quarter)
-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M-1.69M
Income towards Parent Company (Quarter)
-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-66.40M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-2.49M-4.77M-6.41M-2.27M-7.66M-1.69M
Net Income towards Common Stockholders (Quarter)
-5.25M3.08M-5.50M-8.45M-4.76M-8.16M-67.20M-1.58M-1.93M-0.67M-2.67M-4.22M-4.12M-10.79M-4.77M-6.41M-2.27M-7.66M-3.04M
Additional items
EPS (Basic) (Quarter)
-1.28-33.58-37.40-0.27-0.02-4.362.02-24.65-3.89-2.83-0.61-3.60-5.57-38.1749.36-0.36-0.38-1.70-2.88-1.39
EPS (Weighted Average and Diluted) (Quarter)
-57.64-37.40-4.362.02
Shares Outstanding (Weighted Average) (Quarter)
3.51M128.000.10M400.75M525.92M1,092.24M1.03M2.73M0.41M0.68M1.10M0.74M0.75M0.11M0.17M18.12M20.50M1.08M1.42M2.19M
Shares Outstanding (Diluted Average) (Quarter)
128.000.10M0.00M1.03M
EBITDA (Quarter)
-7.24M-7.39M-8.26M-5.50M-8.46M-4.78M-8.21M-66.48M-6.31M-2.73M-2.60M-2.62M-2.72M-2.86M-3.05M-3.58M-4.69M-3.02M-9.86M-2.32M
Interest Expenses (Quarter)
0.03M-0.02M0.00M0.01M0.03M-0.03M0.05M0.07M0.08M0.05M0.10M
Tax Rate (Quarter)
-0.04%-26.33%9.38%